APC c.1451A>C ;(p.E484A)

Variant ID: 5-112162847-A-C

NM_000038.5(APC):c.1451A>C;(p.E484A)

This variant was identified in 41 publications

View GRCh38 version.




Publications:


Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.

Communications Medicine
Berry, Catherine C; Pavot, Vincent V; Anosova, Natalie G NG; Kishko, Michael M; Li, Lu L; Tibbitts, Tim T; Raillard, Alice A; Gautheron, Sylviane S; Cummings, Sheila S; Bangari, Dinesh S DS; Kar, Swagata S; Atyeo, Caroline C; Deng, Yixiang Y; Alter, Galit G; Gutzeit, Cindy C; Koutsoukos, Marguerite M; Chicz, Roman M RM; Lecouturier, Valerie V
Publication Date: 2023-05-26

Variant appearance in text: APC: E484A
PubMed Link: 37237062
Variant Present in the following documents:
  • Main text
  • 43856_2023_Article_302.pdf
View BVdb publication page



Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds.

Signal Transduction And Targeted Therapy
Cui, Zhen Z; Luo, Wenxin W; Chen, Ruihong R; Li, Yalun Y; Wang, Zhoufeng Z; Liu, Yong Y; Liu, Shuo S; Feng, LeiLei L; Jia, Zijing Z; Cheng, Ruixin R; Tang, Jun J; Huang, Weijin W; Zhang, Yanjun Y; Liu, Huawen H; Wang, Xiangxi X; Li, Weimin W
Publication Date: 2023-05-04

Variant appearance in text: APC: E484A
PubMed Link: 37142583
Variant Present in the following documents:
  • Main text
  • 41392_2023_Article_1422.pdf
View BVdb publication page



Toward a Pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses.

Plos Pathogens
Wang, Chang Yi CY; Peng, Wen-Jiun WJ; Kuo, Be-Sheng BS; Ho, Yu-Hsin YH; Wang, Min-Sheng MS; Yang, Ya-Ting YT; Chang, Po-Yen PY; Shen, Yea-Huei YH; Hwang, Kao-Pin KP
Publication Date: 2023-04-20

Variant appearance in text: APC: E484A
PubMed Link: 37079651
Variant Present in the following documents:
  • Main text
  • ppat.1010870.pdf
View BVdb publication page



Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection.

Nature Communications
Pieren, Daan K J DKJ; Kuguel, Sebastián G SG; Rosado, Joel J; Robles, Alba G AG; Rey-Cano, Joan J; Mancebo, Cristina C; Esperalba, Juliana J; Falcó, Vicenç V; Buzón, María J MJ; Genescà, Meritxell M
Publication Date: 2023-04-05

Variant appearance in text: APC: E484A
PubMed Link: 37019909
Variant Present in the following documents:
  • Main text
  • 41467_2023_Article_37559.pdf
View BVdb publication page



Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.

Medrxiv : The Preprint Server For Health Sciences
Moyo-Gwete, Thandeka T; Richardson, Simone I SI; Keeton, Roanne R; Hermanus, Tandile T; Spencer, Holly H; Manamela, Nelia P NP; Ayres, Frances F; Makhado, Zanele Z; Motlou, Thopisang T; Tincho, Marius B MB; Benede, Ntombi N; Ngomti, Amkele A; Baguma, Richard R; Chauke, Masego V MV; Mennen, Mathilda M; Adriaanse, Marguerite M; Skelem, Sango S; Goga, Ameena A; Garrett, Nigel N; Bekker, Linda-Gail LG; Gray, Glenda G; Ntusi, Ntobeko A B NAB; Riou, Catherine C; Burgers, Wendy A WA; Moore, Penny L PL
Publication Date: 2023-03-15

Variant appearance in text: APC: E484A
PubMed Link: 36993404
Variant Present in the following documents:
  • Main text
  • nihpp-2023.03.15.23287288v1.pdf
View BVdb publication page



Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.

Nature Communications
Chen, Wei-Hung WH; Hajduczki, Agnes A; Martinez, Elizabeth J EJ; Bai, Hongjun H; Matz, Hanover H; Hill, Thomas M TM; Lewitus, Eric E; Chang, William C WC; Dawit, Layla L; Peterson, Caroline E CE; Rees, Phyllis A PA; Ajayi, Adelola B AB; Golub, Emily S ES; Swafford, Isabella I; Dussupt, Vincent V; David, Sapna S; Mayer, Sandra V SV; Soman, Sandrine S; Kuklis, Caitlin C; Corbitt, Courtney C; King, Jocelyn J; Choe, Misook M; Sankhala, Rajeshwer S RS; Thomas, Paul V PV; Zemil, Michelle M; Wieczorek, Lindsay L; Hart, Tricia T; Duso, Debora D; Kummer, Larry L; Yan, Lianying L; Sterling, Spencer L SL; Laing, Eric D ED; Broder, Christopher C CC; Williams, Jazmean K JK; Davidson, Edgar E; Doranz, Benjamin J BJ; Krebs, Shelly J SJ; Polonis, Victoria R VR; Paquin-Proulx, Dominic D; Rolland, Morgane M; Reiley, William W WW; Gromowski, Gregory D GD; Modjarrad, Kayvon K; Dooley, Helen H; Joyce, M Gordon MG
Publication Date: 2023-02-03

Variant appearance in text: APC: E484A
PubMed Link: 36737435
Variant Present in the following documents:
  • Main text
  • 41467_2023_Article_36106.pdf
View BVdb publication page



Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.

Cell Discovery
Ai, Liangxia L; Li, Yafei Y; Zhou, Li L; Yao, Wenrong W; Zhang, Hao H; Hu, Zhaoyu Z; Han, Jinyu J; Wang, Weijie W; Wu, Junmiao J; Xu, Pan P; Wang, Ruiyue R; Li, Zhangyi Z; Li, Zhouwang Z; Wei, Chengliang C; Liang, Jianqun J; Chen, Haobo H; Yang, Zhimiao Z; Guo, Ming M; Huang, Zhixiang Z; Wang, Xin X; Zhang, Zhen Z; Xiang, Wenjie W; Sun, Dazheng D; Xu, Lianqiang L; Huang, Meiyan M; Lv, Bin B; Peng, Peiqi P; Zhang, Shangfeng S; Ji, Xuhao X; Luo, Huiyi H; Chen, Nanping N; Chen, Jianping J; Lan, Ke K; Hu, Yong Y
Publication Date: 2023-01-23

Variant appearance in text: APC: E484A
PubMed Link: 36683074
Variant Present in the following documents:
  • Main text
  • 41421_2022_Article_517.pdf
View BVdb publication page



A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants.

Acta Pharmaceutica Sinica. B
Qin, Shugang S; Huang, Hai H; Xiao, Wen W; Chen, Kepan K; He, Xi X; Tang, Xiaoshan X; Huang, Zhiying Z; Zhang, Yupei Y; Duan, Xing X; Fan, Na N; Zheng, Qian Q; Wu, Min M; Lu, Guangwen G; Wei, Yuqan Y; Wei, Xiawei X; Song, Xiangrong X
Publication Date: 2023-01-12

Variant appearance in text: APC: E484A
PubMed Link: 36647424
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant.

Cell Reports. Medicine
Richardson, Simone I SI; Kgagudi, Prudence P; Manamela, Nelia P NP; Kaldine, Haajira H; Venter, Elizabeth M EM; Pillay, Thanusha T; Lambson, Bronwen E BE; van der Mescht, Mieke A MA; Hermanus, Tandile T; Balla, Sashkia R SR; de Beer, Zelda Z; de Villiers, Talita R TR; Bodenstein, Annie A; van den Berg, Gretha G; du Pisanie, Marizane M; Burgers, Wendy A WA; Ntusi, Ntobeko A B NAB; Abdullah, Fareed F; Ueckermann, Veronica V; Rossouw, Theresa M TM; Boswell, Michael T MT; Moore, Penny L PL
Publication Date: 2022-12-22

Variant appearance in text: APC: E484A
PubMed Link: 36603577
Variant Present in the following documents:
  • Main text
  • mmc2.pdf
  • main.pdf
View BVdb publication page



Impact of SARS-CoV-2 exposure history on the T cell and IgG response.

Cell Reports. Medicine
Keeton, Roanne R; Tincho, Marius B MB; Suzuki, Akiko A; Benede, Ntombi N; Ngomti, Amkele A; Baguma, Richard R; Chauke, Masego V MV; Mennen, Mathilda M; Skelem, Sango S; Adriaanse, Marguerite M; Grifoni, Alba A; Weiskopf, Daniela D; Sette, Alessandro A; Bekker, Linda-Gail LG; Gray, Glenda G; Ntusi, Ntobeko A B NAB; Burgers, Wendy A WA; Riou, Catherine C
Publication Date: 2022-12-22

Variant appearance in text: APC: E484A
PubMed Link: 36584684
Variant Present in the following documents:
  • Main text
  • mmc2.pdf
  • main.pdf
View BVdb publication page



The second COVID-19 mRNA vaccine dose enhances the capacity of Spike RBD-specific memory B cells to bind Omicron BA.2.

Allergy
Hartley, Gemma E GE; Edwards, Emily S J ESJ; Varese, Nirupama N; Boo, Irene I; Aui, Pei M PM; Bornheimer, Scott J SJ; Hogarth, P Mark PM; Drummer, Heidi E HE; O'Hehir, Robyn E RE; van Zelm, Menno C MC
Publication Date: 2022-12-21

Variant appearance in text: APC: E484A
PubMed Link: 36541822
Variant Present in the following documents:
  • ALL-9999-0.pdf
View BVdb publication page



COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan.

Cell Discovery
Liang, Hong H; Nian, Xuanxuan X; Wu, Junzheng J; Liu, Dong D; Feng, Lu L; Lu, Jia J; Peng, Yan Y; Zhou, Zhijun Z; Deng, Tao T; Liu, Jing J; Ji, Deming D; Qiu, Ran R; Lin, Lianzhen L; Zeng, Yan Y; Xia, Fei F; Hu, Yong Y; Li, Taojing T; Duan, Kai K; Li, Xinguo X; Wang, Zejun Z; Zhang, Yong Y; Zhang, Hang H; Zhu, Chen C; Wang, Shang S; Wu, Xiao X; Wang, Xiang X; Li, Yuwei Y; Huang, Shihe S; Mao, Min M; Guo, Huanhuan H; Yang, Yunkai Y; Jia, Rui R; Xufang, Jingwei J; Wang, Xuewei X; Liang, Shuyan S; Qiu, Zhixin Z; Zhang, Juan J; Ding, Yaling Y; Li, Chunyan C; Zhang, Jin J; Fu, Daoxing D; He, Yanlin Y; Zhou, Dongbo D; Li, Cesheng C; Zhang, Jiayou J; Yu, Ding D; Yang, Xiao-Ming XM
Publication Date: 2022-12-09

Variant appearance in text: APC: E484A
PubMed Link: 36494338
Variant Present in the following documents:
  • 41421_2022_496_MOESM1_ESM.pdf
View BVdb publication page



CD8<sup>+</sup> T-cell immune escape by SARS-CoV-2 variants of concern.

Frontiers In Immunology
Kombe Kombe, Arnaud John AJ; Biteghe, Fleury Augustin Nsole FAN; Ndoutoume, Zélia Nelly ZN; Jin, Tengchuan T
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 36389664
Variant Present in the following documents:
  • Main text
View BVdb publication page



Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness.

Vaccines
Tulimilli, SubbaRao V SV; Dallavalasa, Siva S; Basavaraju, Chaithanya G CG; Kumar Rao, Vinay V; Chikkahonnaiah, Prashanth P; Madhunapantula, SubbaRao V SV; Veeranna, Ravindra P RP
Publication Date: 2022-10-19

Variant appearance in text: APC: E484A
PubMed Link: 36298616
Variant Present in the following documents:
  • Main text
View BVdb publication page



Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern.

Iscience
Sun, Peifang P; Ramos, Irene I; Coelho, Camila H CH; Grifoni, Alba A; Balinsky, Corey A CA; Vangeti, Sindhu S; Tarke, Alison A; Bloom, Nathaniel I NI; Jani, Vihasi V; Jakubski, Silvia J SJ; Boulifard, David A DA; Cooper, Elizabeth E; Goforth, Carl W CW; Marayag, Jan J; Marrone, Amethyst A; Nunez, Edgar E; White, Lindsey L; Porter, Chad K CK; Sugiharto, Victor A VA; Schilling, Megan M; Mahajan, Avinash S AS; Beckett, Charmagne C; Sette, Alessandro A; Sealfon, Stuart C SC; Crotty, Shane S; Letizia, Andrew G AG
Publication Date: 2022-10-21

Variant appearance in text: APC: E484A
PubMed Link: 36168391
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2.

Embo Molecular Medicine
Zhang, Lianghui L; Narayanan, Krishna K KK; Cooper, Laura L; Chan, Kui K KK; Skeeters, Savanna S SS; Devlin, Christine A CA; Aguhob, Aaron A; Shirley, Kristie K; Rong, Lijun L; Rehman, Jalees J; Malik, Asrar B AB; Procko, Erik E
Publication Date: 2022-11-08

Variant appearance in text: APC: E484A
PubMed Link: 36094679
Variant Present in the following documents:
  • Main text
  • EMMM-9999-0-s003.pdf
  • EMMM-9999-0.pdf
View BVdb publication page



Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses.

Frontiers In Immunology
Lin, Yajie Y; Zhu, Jiajie J; Liu, Zongming Z; Li, Chaonan C; Guo, Yikai Y; Wang, Ying Y; Chen, Keda K
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 35990623
Variant Present in the following documents:
  • Main text
  • fimmu-13-864278.pdf
View BVdb publication page



Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.

Cell Reports. Medicine
Naaber, Paul P; Tserel, Liina L; Kangro, Kadri K; Punapart, Marite M; Sepp, Epp E; Jürjenson, Virge V; Kärner, Jaanika J; Haljasmägi, Liis L; Haljasorg, Uku U; Kuusk, Marilin M; Sankovski, Eve E; Planken, Anu A; Ustav, Mart M; Žusinaite, Eva E; Gerhold, Joachim M JM; Kisand, Kai K; Peterson, Pärt P
Publication Date: 2022-08-16

Variant appearance in text: APC: E484A
PubMed Link: 35952669
Variant Present in the following documents:
  • mmc2.pdf
  • main.pdf
View BVdb publication page



Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.

Communications Biology
Li, Ruofan R; Mor, Michael M; Ma, Bingting B; Clark, Alex E AE; Alter, Joel J; Werbner, Michal M; Lee, Jamie Casey JC; Leibel, Sandra L SL; Carlin, Aaron F AF; Dessau, Moshe M; Gal-Tanamy, Meital M; Croker, Ben A BA; Xiang, Ye Y; Freund, Natalia T NT
Publication Date: 2022-08-05

Variant appearance in text: APC: E484A
PubMed Link: 35931732
Variant Present in the following documents:
  • Main text
  • 42003_2022_Article_3739.pdf
View BVdb publication page



The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines.

Vaccines
Sun, Zhongjie Z; Wu, Tingxin T; Xie, Huangfan H; Li, Yuhuan Y; Zhang, Jinlan J; Su, Xuncheng X; Qi, Hailong H
Publication Date: 2022-07-09

Variant appearance in text: APC: E484A
PubMed Link: 35891267
Variant Present in the following documents:
  • Main text
  • vaccines-10-01103.pdf
View BVdb publication page



Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s.

Cell Discovery
Li, Linjie L; Han, Pu P; Huang, Baihan B; Xie, Yufeng Y; Li, Weiwei W; Zhang, Di D; Han, Pengcheng P; Xu, Zepeng Z; Bai, Bin B; Zhou, Jingya J; Kang, Xinrui X; Li, Xiaomei X; Zheng, Anqi A; Zhang, Rong R; Qiao, Shitong S; Zhao, Xin X; Qi, Jianxun J; Wang, Qihui Q; Liu, Kefang K; Gao, George Fu GF
Publication Date: 2022-07-12

Variant appearance in text: APC: E484A
PubMed Link: 35821014
Variant Present in the following documents:
  • Main text
  • 41421_2022_Article_431.pdf
View BVdb publication page



Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination.

Cells
Astakhova, Ekaterina A EA; Byazrova, Maria G MG; Yusubalieva, Gaukhar M GM; Kulemzin, Sergey V SV; Kruglova, Natalia A NA; Prilipov, Alexey G AG; Baklaushev, Vladimir P VP; Gorchakov, Andrey A AA; Taranin, Alexander V AV; Filatov, Alexander V AV
Publication Date: 2022-06-21

Variant appearance in text: APC: E484A
PubMed Link: 35805076
Variant Present in the following documents:
  • Main text
  • cells-11-01991.pdf
View BVdb publication page



Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses.

Nature Communications
Xu, Zepeng Z; Kang, Xinrui X; Han, Pu P; Du, Pei P; Li, Linjie L; Zheng, Anqi A; Deng, Chuxia C; Qi, Jianxun J; Zhao, Xin X; Wang, Qihui Q; Liu, Kefang K; Gao, George Fu GF
Publication Date: 2022-06-21

Variant appearance in text: APC: E484A
PubMed Link: 35729237
Variant Present in the following documents:
  • Main text
  • 41467_2022_Article_31276.pdf
View BVdb publication page



Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review.

Journal Of Medical Virology
K, Akash A; Sharma, Avinash A; Kumar, Deepak D; Singh, Sachin K SK; Gupta, Gaurav G; Chellappan, Dinesh K DK; Dua, Kamal K; Nagraik, Rupak R
Publication Date: 2022-10

Variant appearance in text: APC: E484A
PubMed Link: 35705439
Variant Present in the following documents:
  • Main text
  • JMV-9999-0.pdf
View BVdb publication page



Role of COVID-19 Vaccines in SARS-CoV-2 Variants.

Frontiers In Immunology
Zhou, Zhou Z; Zhu, Yimiao Y; Chu, Ming M
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 35669787
Variant Present in the following documents:
  • Main text
  • fimmu-13-898192.pdf
View BVdb publication page



Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift.

Mabs
Laroche, Adrien A; Orsini Delgado, Maria Lucia ML; Chalopin, Benjamin B; Cuniasse, Philippe P; Dubois, Steven S; Sierocki, Raphaël R; Gallais, Fabrice F; Debroas, Stéphanie S; Bellanger, Laurent L; Simon, Stéphanie S; Maillère, Bernard B; Nozach, Hervé H
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 35593235
Variant Present in the following documents:
  • Main text
  • KMAB_14_2076775.pdf
View BVdb publication page



SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance.

Frontiers In Immunology
Guo, Yifei Y; Han, Jiajia J; Zhang, Yao Y; He, Jingjing J; Yu, Weien W; Zhang, Xueyun X; Wu, Jingwen J; Zhang, Shenyan S; Kong, Yide Y; Guo, Yue Y; Lin, Yanxue Y; Zhang, Jiming J
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 35572518
Variant Present in the following documents:
  • Main text
  • fimmu-13-877101.pdf
View BVdb publication page



Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron.

Frontiers In Immunology
Casasnovas, José M JM; Margolles, Yago Y; Noriega, María A MA; Guzmán, María M; Arranz, Rocío R; Melero, Roberto R; Casanova, Mercedes M; Corbera, Juan Alberto JA; Jiménez-de-Oya, Nereida N; Gastaminza, Pablo P; Garaigorta, Urtzi U; Saiz, Juan Carlos JC; Martín-Acebes, Miguel Ángel MÁ; Fernández, Luis Ángel LÁ
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 35547740
Variant Present in the following documents:
  • Main text
  • fimmu-13-863831.pdf
View BVdb publication page



Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.

Blood
Atanackovic, Djordje D; Luetkens, Tim T; Omili, Destiny D; Iraguha, Thierry T; Lutfi, Forat F; Hardy, Nancy M NM; Fan, Xiaoxuan X; Avila, Stephanie V SV; Saharia, Kapil K KK; Husson, Jennifer S JS; Niederhaus, Silke V SV; Margiotta, Philip P; Lee, Seung T ST; Law, Jennie Y JY; Mannuel, Heather D HD; Vander Mause, Erica E; Bauman, Sherri S; Lesho, Patricia P; Hankey, Kim K; Baddley, John J; Kocoglu, Mehmet M; Yared, Jean A JA; Rapoport, Aaron P AP; Dahiya, Saurabh S
Publication Date: 2022-07-14

Variant appearance in text: APC: E484A
PubMed Link: 35537186
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern.

Cell Reports. Medicine
Kitchin, Dale D; Richardson, Simone I SI; van der Mescht, Mieke A MA; Motlou, Thopisang T; Mzindle, Nonkululeko N; Moyo-Gwete, Thandeka T; Makhado, Zanele Z; Ayres, Frances F; Manamela, Nelia P NP; Spencer, Holly H; Lambson, Bronwen B; Oosthuysen, Brent B; Kaldine, Haajira H; du Pisanie, Marizane M; Mennen, Mathilda M; Skelem, Sango S; Williams, Noleen N; Ntusi, Ntobeko A B NAB; Burgers, Wendy A WA; Gray, Glenda G GG; Bekker, Linda-Gail LG; Boswell, Michael T MT; Rossouw, Theresa M TM; Ueckermann, Veronica V; Moore, Penny L PL
Publication Date: 2022-03-15

Variant appearance in text: APC: E484A
PubMed Link: 35474744
Variant Present in the following documents:
  • Main text
  • mmc2.pdf
  • main.pdf
View BVdb publication page



SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals.

Cell Host & Microbe
Richardson, Simone I SI; Madzorera, Vimbai Sharon VS; Spencer, Holly H; Manamela, Nelia P NP; van der Mescht, Mieke A MA; Lambson, Bronwen E BE; Oosthuysen, Brent B; Ayres, Frances F; Makhado, Zanele Z; Moyo-Gwete, Thandeka T; Mzindle, Nonkululeko N; Motlou, Thopisang T; Strydom, Amy A; Mendes, Adriano A; Tegally, Houriiyah H; de Beer, Zelda Z; Roma de Villiers, Talita T; Bodenstein, Annie A; van den Berg, Gretha G; Venter, Marietjie M; de Oliviera, Tulio T; Ueckermann, Veronica V; Rossouw, Theresa M TM; Boswell, Michael T MT; Moore, Penny L PL
Publication Date: 2022-06-08

Variant appearance in text: APC: E484A
PubMed Link: 35436444
Variant Present in the following documents:
  • Main text
  • mmc2.pdf
  • main.pdf
View BVdb publication page



An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2.

Biorxiv : The Preprint Server For Biology
Zhang, Lianghui L; Narayanan, Krishna K KK; Cooper, Laura L; Chan, Kui K KK; Devlin, Christine A CA; Aguhob, Aaron A; Shirley, Kristie K; Rong, Lijun L; Rehman, Jalees J; Malik, Asrar B AB; Procko, Erik E
Publication Date: 2022-03-28

Variant appearance in text: APC: E484A
PubMed Link: 35378764
Variant Present in the following documents:
  • Main text
  • nihpp-2022.03.28.486075v1.pdf
View BVdb publication page



Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529.

Science (New York, N.Y.)
Zhou, Tongqing T; Wang, Lingshu L; Misasi, John J; Pegu, Amarendra A; Zhang, Yi Y; Harris, Darcy R DR; Olia, Adam S AS; Talana, Chloe Adrienna CA; Yang, Eun Sung ES; Chen, Man M; Choe, Misook M; Shi, Wei W; Teng, I-Ting IT; Creanga, Adrian A; Jenkins, Claudia C; Leung, Kwanyee K; Liu, Tracy T; Stancofski, Erik-Stephane D ED; Stephens, Tyler T; Zhang, Baoshan B; Tsybovsky, Yaroslav Y; Graham, Barney S BS; Mascola, John R JR; Sullivan, Nancy J NJ; Kwong, Peter D PD
Publication Date: 2022-04-22

Variant appearance in text: APC: E484A
PubMed Link: 35324257
Variant Present in the following documents:
  • Main text
  • science.abn8897.pdf
  • science.abn8897.v1.pdf
View BVdb publication page



Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.

Frontiers In Immunology
Kurahashi, Yukiya Y; Sutandhio, Silvia S; Furukawa, Koichi K; Tjan, Lidya Handayani LH; Iwata, Sachiyo S; Sano, Shigeru S; Tohma, Yoshiki Y; Ohkita, Hiroyuki H; Nakamura, Sachiko S; Nishimura, Mitsuhiro M; Arii, Jun J; Kiriu, Tatsunori T; Yamamoto, Masatsugu M; Nagano, Tatsuya T; Nishimura, Yoshihiro Y; Mori, Yasuko Y
Publication Date: 2022

Variant appearance in text: APC: E484A
PubMed Link: 35281007
Variant Present in the following documents:
  • fimmu-13-773652.pdf
View BVdb publication page



Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.

Biorxiv : The Preprint Server For Biology
Goel, Rishi R RR; Painter, Mark M MM; Lundgreen, Kendall A KA; Apostolidis, Sokratis A SA; Baxter, Amy E AE; Giles, Josephine R JR; Mathew, Divij D; Pattekar, Ajinkya A; Reynaldi, Arnold A; Khoury, David S DS; Gouma, Sigrid S; Hicks, Philip P; Dysinger, Sarah S; Hicks, Amanda A; Sharma, Harsh H; Herring, Sarah S; Korte, Scott S; Kc, Wumesh W; Oldridge, Derek A DA; Erickson, Rachel I RI; Weirick, Madison E ME; McAllister, Christopher M CM; Awofolaju, Moses M; Tanenbaum, Nicole N; Dougherty, Jeanette J; Long, Sherea S; D'Andrea, Kurt K; Hamilton, Jacob T JT; McLaughlin, Maura M; Williams, Justine C JC; Adamski, Sharon S; Kuthuru, Oliva O; Drapeau, Elizabeth M EM; Davenport, Miles P MP; Hensley, Scott E SE; Bates, Paul P; Greenplate, Allison R AR; Wherry, E John EJ
Publication Date: 2022-02-22

Variant appearance in text: APC: E484A
PubMed Link: 35233575
Variant Present in the following documents:
  • nihpp-2022.02.20.481163v1.pdf
View BVdb publication page